FDA 483 - N-Molecular, Inc. dba SOFIE - January 13, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of M-Molecular, Inc. dba SOFIE, a PET drug manufacturer in Colonie, NY, revealed significant deficiencies in quality control and personnel training. Observations included a failure to verify an established analytical test procedure for Fludeoxyglucose F-18 (FDG) release testing. Additionally, the firm did not implement adequate corrective actions for recurring out-of-specification results caused by poor laboratory practices and lacked necessary GMP training records for manufacturing personnel.
ID · 81a5c5d1-39a2-4215-8d0a-e9f50174e667